187 related articles for article (PubMed ID: 29877779)
1. Impulsivity in Alcohol-Dependent Patients with and without ADHD: The Role of Atomoxetine.
Coppola M; Mondola R
J Psychoactive Drugs; 2018; 50(4):361-366. PubMed ID: 29877779
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of atomoxetine in treating adult attention deficit hyperactivity disorder (ADHD): A meta-analysis of controlled trials.
Ravishankar V; Chowdappa SV; Benegal V; Muralidharan K
Asian J Psychiatr; 2016 Dec; 24():53-58. PubMed ID: 27931908
[TBL] [Abstract][Full Text] [Related]
3. Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation.
Grassi G; Micheli L; Di Cesare Mannelli L; Compagno E; Righi L; Ghelardini C; Pallanti S
J Psychiatr Res; 2016 Dec; 83():240-248. PubMed ID: 27665536
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study.
Harfterkamp M; Buitelaar JK; Minderaa RB; van de Loo-Neus G; van der Gaag RJ; Hoekstra PJ
J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):194-9. PubMed ID: 23578015
[TBL] [Abstract][Full Text] [Related]
5. Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
Handen BL; Aman MG; Arnold LE; Hyman SL; Tumuluru RV; Lecavalier L; Corbett-Dick P; Pan X; Hollway JA; Buchan-Page KA; Silverman LB; Brown NV; Rice RR; Hellings J; Mruzek DW; McAuliffe-Bellin S; Hurt EA; Ryan MM; Levato L; Smith T
J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):905-15. PubMed ID: 26506581
[TBL] [Abstract][Full Text] [Related]
6. The Atxn7-overexpressing mice showed hyperactivity and impulsivity which were ameliorated by atomoxetine treatment: A possible animal model of the hyperactive-impulsive phenotype of ADHD.
Dela Peña IJI; Botanas CJ; de la Peña JB; Custodio RJ; Dela Peña I; Ryoo ZY; Kim BN; Ryu JH; Kim HJ; Cheong JH
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():311-319. PubMed ID: 30125623
[TBL] [Abstract][Full Text] [Related]
7. Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.
Kilincaslan A; Mutluer TD; Pasabeyoglu B; Tutkunkardas MD; Mukaddes NM
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):798-806. PubMed ID: 27228116
[TBL] [Abstract][Full Text] [Related]
8. Atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder.
Wietecha LA; Williams DW; Herbert M; Melmed RD; Greenbaum M; Schuh K
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):719-30. PubMed ID: 20035590
[TBL] [Abstract][Full Text] [Related]
9. Atomoxetine-Related Trichotillomania in a Boy with Attention-Deficit/Hyperactivity Disorder.
Akaltun İ; Kara T
J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):923. PubMed ID: 29099621
[No Abstract] [Full Text] [Related]
10. Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.
Brown JT; Bishop JR; Sangkuhl K; Nurmi EL; Mueller DJ; Dinh JC; Gaedigk A; Klein TE; Caudle KE; McCracken JT; de Leon J; Leeder JS
Clin Pharmacol Ther; 2019 Jul; 106(1):94-102. PubMed ID: 30801677
[TBL] [Abstract][Full Text] [Related]
11. Impulsive Personality Traits Mediate the Relationship Between Adult Attention-Deficit/Hyperactivity Symptoms and Alcohol Dependence Severity.
Daurio AM; Aston SA; Schwandt ML; Bukhari MO; Bouhlal S; Farokhnia M; Lee MR; Leggio L
Alcohol Clin Exp Res; 2018 Jan; 42(1):173-183. PubMed ID: 29063627
[TBL] [Abstract][Full Text] [Related]
12. Open-label, dose-titration tolerability study of atomoxetine hydrochloride in Korean, Chinese, and Taiwanese adults with attention-deficit/hyperactivity disorder.
Takahashi M; Goto T; Takita Y; Chung SK; Wang Y; Gau SS
Asia Pac Psychiatry; 2014 Mar; 6(1):62-70. PubMed ID: 23857916
[TBL] [Abstract][Full Text] [Related]
13. Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence.
Adler L; Wilens T; Zhang S; Durell T; Walker D; Schuh L; Jin L; Feldman P; Trzepacz P
Am J Addict; 2009; 18(5):393-401. PubMed ID: 19874159
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHD.
Goto T; Hirata Y; Takita Y; Trzepacz PT; Allen AJ; Song DH; Gau SS; Ichikawa H; Takahashi M
J Atten Disord; 2017 Jan; 21(2):100-109. PubMed ID: 24203774
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study.
Troost PW; Steenhuis MP; Tuynman-Qua HG; Kalverdijk LJ; Buitelaar JK; Minderaa RB; Hoekstra PJ
J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):611-9. PubMed ID: 17069549
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of atomoxetine for symptoms of attention-deficit/hyperactivity disorder in children with a history of child abuse.
Sugimoto A; Suzuki Y; Endo T; Matsumoto K; Sugiyama T; Someya T
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):269-71. PubMed ID: 25885013
[TBL] [Abstract][Full Text] [Related]
17. Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.
Simpson D; Plosker GL
Drugs; 2004; 64(2):205-22. PubMed ID: 14717619
[TBL] [Abstract][Full Text] [Related]
18. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
McClain MB; Hasty Mills AM; Murphy LE
Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
[TBL] [Abstract][Full Text] [Related]
19. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial.
Adler LA; Spencer T; Brown TE; Holdnack J; Saylor K; Schuh K; Trzepacz PT; Williams DW; Kelsey D
J Clin Psychopharmacol; 2009 Feb; 29(1):44-50. PubMed ID: 19142107
[TBL] [Abstract][Full Text] [Related]
20. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
